| Literature DB >> 36013291 |
Henrik Constantin Bäcker1,2, Chia H Wu3, Dominik Pförringer4, Wolf Petersen5, Ulrich Stöckle1, Karl F Braun4,5.
Abstract
Following the outbreak of SARS-CoV-2, several elective surgeries were cancelled, and rehabilitation units were closed. This has led to difficulties for patients seeking access to rehabilitation in order to achieve the best possible outcome. New applications with or without sensors were developed to address this need, but the outcome has not been examined in detail yet. The aim of this study was to perform a systematic literature review on smart phone applications for patients suffering from hip and knee osteoarthritis after arthroplasty. The MEDLINE/PubMed and Google databases were queried using the search term "[APP] AND [ORTHOPEDIC]" according to PRISMA guidelines. All prospective studies investigating rehabilitation applications reporting the functional outcome in hip and knee osteoarthritis after arthroplasty were included. The initial search yielded 420 entries, but only 9 publications met the inclusion criteria, accounting for 1067 patients. In total, 518 patients were in the intervention group, and 549 patients were in the control group. The average follow-up was 9.5 ± 8.1 months (range: 3 to 23.4 months). Overall, significantly lower A-VAS values were observed for the interventional group in the short term (p = 0.002). There were no other significant differences observed between the two groups. Smart phone applications provide an alternative to in-person sessions that may improve access for patients after total joint arthroplasty. Our study found there are significant improvements in the short term by using this approach. In combination with a blue-tooth-enabled sensor for isometric exercises, patients can even receive real-time feedback after total knee arthroplasty.Entities:
Keywords: applications; hip; knee; osteoarthritis; rehabilitation
Year: 2022 PMID: 36013291 PMCID: PMC9409922 DOI: 10.3390/jpm12081342
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Included articles according to the PRISMA Guidelines.
Included studies and demographics of patients included.
| Author | Year | No. Patients | Age (Year) | Gender (Male) (No.) | BMI (kg/m2) | Follow-Up (Months) | Digital Program | Indication | Hospital Stay (Days) | Days of Intervention | Comorbidities (No.) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Arfaei Chitkar SS | 2021 | 31 | 57.84 | 27.97 | Application instruction | Knee osteoarthritis | 56 | 7 | |||
| Control group | 29 | 58.52 | 26.62 | 56 | 5 | ||||||
| Bäcker HC | 2021 | 20 | 62.95 | 8 | 32.33 | 23.73 | Application with sensor | TKA | 6.6 | 1 | |
| Control group | 15 | 66.27 | 6 | 33.79 | 23.35 | 6.9 | 1 | ||||
| Correia FD | 2019 | 38 | 67.3 | 32 | 31.0 | 6 | Application with motion tracker | TKA | 6.0 | 56 | Detailed listing |
| Control group | 31 | 70.0 | 22 | 30.8 | 6 | 6.0 | 56 | Detailed listing | |||
| Hardt S | 2018 | 22 | 63.3 | 10 | 31.6 | 7 | Application with sensor | TKA | 6.6 | 6.6 | 1 |
| Control group | 25 | 67.6 | 10 | 32.4 | 7 | 6.9 | 6.9 | 1 | |||
| Li I | 2020 | 44 | 65 | Application instruction | Arthritis | 14.7 | 14.7 | 4 | |||
| Control group | 44 | 66 | 14.2 | 14.2 | 4 | ||||||
| Pelle T | 2020 | 214 | 62.1 | 67 | 27.8 | Application instruction | Osteoarthritis | ||||
| Control group | 213 | 62.1 | 54 | 27.3 | |||||||
| Skrepnik N | 2017 | 107 | 61.6 | 48 | 29.4 | 3 | Application with sensor | Osteoarthritis | |||
| Control group | 104 | 63.6 | 57 | 29.3 | 3 | ||||||
| Control group | 61 | 66.0 | 40 | 27.73 | |||||||
| Van Dijk-Huisman HC | 2020 | 27 | 65.1 | 15 | 27.47 | Application with sensor | TKA | 31 | |||
| Control group | 61 | 66.0 | 40 | 27.73 | 31 | ||||||
| Wijnen A | 2020 | 15 | 59.3 | 5 | 26.7 | 6 | Application instruction | THA | 84 | ||
| Control group | 15 | 59.3 | 5 | 28 | 84 | ||||||
| Control group | 12 | 59.3 | 5 | 31.1 | 84 | ||||||
| Intervention group | 518 | 62.7 + 2.9 | 443 (41.8%) | 29.3 + 2.1 | 9.2 + 8.3 | 9.1 + 4.9 | 3.3 + 2.9 | ||||
| Control group | 549 | 63.9 + 3.9 | 467 (41.8%) | 29.7 + 2.5 | 9.8 + 9.2 | 9.0 + 4.5 | 2.8 + 2.1 | ||||
| 0.243 | 0.449 | 0.368 | 0.454 | 0.493 | 0.393 |
PROMs following rehabilitation programs for knee/hip osteoarthritis, as well as following joint replacement. Score indicates the PROM used; overall means, standard deviations and p-values were calculated for HOOS/KOOS and self-management behavior scores, as these are comparable. Empty cells—not reported in the individual studies. N/A—not applicable. Significances presented in bold.
| No. Patients | Six-Minute Endurance | ST | Walking Speed (10 min) | ST | Change in Disability | ST | Score | Pain | ST | LT | Symptoms | ST | LT | Function in ADL | ST | LT | Sport/Recreation | ST | LT | Quality of Life | ST | LT | R-VAS | ST | LT | A-VAS | ST | LT | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arfaei Chitkar SS | 31 | WOMAC | 18.5 | 5.6 | 48.3 | ||||||||||||||||||||||||
| Control group | 29 | WOMAC | 17.2 | 5.6 | 49.6 | ||||||||||||||||||||||||
| Bäcker HC | 20 | 11.77 | 19.66 | KOOS | 42.4 | 56.0 | 81.7 | 50.6 | 61.7 | 64.5 | 45.8 | 54.6 | 77.2 | 16.0 | 9.5 | 48.6 | 18.4 | 26.7 | 68.4 | 3.6 | 2.7 | 0.9 | 7.6 | 4.0 | 2.7 | ||||
| Control group | 15 | 12.39 | 27.08 | KOOS | 37.8 | 53.2 | 80.7 | 48.6 | 63.1 | 61.6 | 40.8 | 51.0 | 77.1 | 9.3 | 8.1 | 47.3 | 14.2 | 30.8 | 67.9 | 4.3 | 3.6 | 0.9 | 6.7 | 5.1 | 2.8 | ||||
| Correia FD | 38 | KOOS | 33.0 | 95.5 | 100.0 | 34.0 | 51.5 | 96.0 | 34.0 | 93.0 | 97.0 | 0 | 30.0 | 42.5 | 13.0 | 81.0 | 94.0 | ||||||||||||
| Control group | 31 | KOOS | 47.0 | 86.0 | 86.0 | 50.0 | 82.0 | 86.0 | 41.0 | 87.0 | 87.0 | 5.0 | 20.0 | 20.0 | 25.0 | 56.0 | 63.0 | ||||||||||||
| Hardt S | 22 | 0.9 | 0.6 | KOOS | 45.0 | 56.0 | 62.0 | 60.0 | 47.0 | 54.0 | 14.0 | 10.0 | 17.0 | 30.0 | 4.0 | 2.0 | 7.0 | 4.0 | |||||||||||
| Control group | 25 | 0.8 | 0.5 | KOOS | 36.0 | 50.0 | 58.0 | 59.0 | 39.0 | 42.0 | 12.0 | 5.0 | 18.0 | 26.0 | 4.0 | 4.0 | 7.0 | 5.0 | |||||||||||
| Li I | 44 | delta = 115.6 | delta = 0.4 | 17.3 | 118.2 | ||||||||||||||||||||||||
| Control group | 44 | delta = 103.3 | delta = 0.4 | 18.0 | 117.5 | ||||||||||||||||||||||||
| Pelle T | 214 | Self-management behavior | 57.5 | 59.5 | 59.4 | 57.7 | 57.3 | 57.3 | 58.5 | 61.4 | 62.1 | 32.6 | 31.9 | 33.4 | 38.0 | ||||||||||||||
| Control group | 213 | Self-management behavior | 58.2 | 57.4 | 57.5 | 57.0 | 56.2 | 55.2 | 59.4 | 58.5 | 58.6 | 32.5 | 33.2 | 33.2 | 38.3 | ||||||||||||||
| Skrepnik N | 107 | 402.8 | 18.2 | 4.6 | delta = −55.3 | ||||||||||||||||||||||||
| Control group | 104 | 395.6 | 6.3 | 5.1 | delta = −33.8 | ||||||||||||||||||||||||
| Van Dijk-Huisman HC | 27 | Standing walking time/functional recovery | 70.9 | −0.3 | |||||||||||||||||||||||||
| Control group | 61 | 103.0 | 1.0 | ||||||||||||||||||||||||||
| Wijnen A | 15 | HOOS | 48.9 | 88.8 | 98.7 | 50.0 | 75.3 | 91.0 | 52.7 | 76.5 | 96.8 | 23.3 | 70.0 | 82.5 | 19.2 | 50.8 | 88.8 | ||||||||||||
| Control group | 15 | HOOS | 35.5 | 71.7 | 85.1 | 29.3 | 68 | 76.3 | 34.0 | 60.6 | 80 | 16.3 | 26.7 | 59.6 | 22.9 | 45.8 | 71.3 | ||||||||||||
| Control group | 12 | HOOS | 36.3 | 73.5 | 85.6 | 41.7 | 62.1 | 77.5 | 37.1 | 58.1 | 79.1 | 20.8 | 29.7 | 64.9 | 24.5 | 43.2 | 69.3 | ||||||||||||
| Intervention group | 518 | 402.8 | 18.2 | 6.34 | 10.13 | 17.3 | 118.2 | 45.36 | 71.16 | 84.95 | 50.86 | 61.16 | 77.2 | 47.6 | 67.9 | 83.275 | 17.18 | 30.28 | 51.75 | 21.12 | 4.07 | 2.35 | 0.9 | 7.3 | 4 | 2.7 | |||
| Std. | N/A | N/A | 7.69 | 13.48 | N/A | N/A | 8.97 | 19.36 | 18.96 | 10.68 | 8.80 | 19.16 | 9.13 | 16.71 | 16.90 | 12.06 | 24.61 | 21.43 | 9.73 | 0.50 | 0.49 | N/A | 0.42 | 0 | N/A | ||||
| Control group | 549 | 395.6 | 6.3 | 6.60 | 13.79 | 18.0 | 41.80 | 65.30 | 78.98 | 47.43 | 65.07 | 71.32 | 41.88 | 59.53 | 76.36 | 15.98 | 20.45 | 45 | 23.82 | 40.36 | 67.88 | 4.47 | 3.8 | 0.9 | 6.85 | 5.05 | 2.8 | ||
| Std. | N/A | N/A | 8.20 | 18.79 | N/A | N/A | 9.12 | 14.00 | 12.20 | 10.70 | 9.20 | 12.58 | 8.97 | 15.09 | 10.61 | 9.77 | 11.65 | 18.57 | 8.23 | 12.04 | 3.54 | 0.57 | 0.28 | N/A | 0.21 | 0.07 | N/A | ||
| N/A | N/A | 0.977 | 0.844 | N/A | N/A | 0.532 | 0.574 | 0.583 | 0.609 | 0.493 | 0.595 | 0.324 | 0.405 | 0.475 | 0.859 | 0.405 | 0.628 | 0.630 | 0.607 | 0.069 | 0.413 | 0.069 | N/A | 0.312 |
| N/A |